Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation: a clinicopathologic study of 5 cases and review of the literature
Adrián Mariño‐Enríquez(Harvard University Press), David Hardisson(Universidad Autónoma de Madrid), Simona Stolnicu(Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș), Marta Mendiola(Hospital Universitario La Paz), Talina González‐Rocha(Universidad de Granada), Francisco F. Nogales(Universidad de Granada), Emilio Burgos(Hospital Universitario Infanta Sofía)
Cited by 22
Related Papers
Imatinib for Melanomas Harboring Mutationally Activated or Amplified <i>KIT</i> Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
|Journal of Clinical Oncology|2013|594
<i>FGFR1</i> Emerges as a Potential Therapeutic Target for Lobular Breast Carcinomas
|Clinical Cancer Research|2006|272
The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
|Endocrine Related Cancer|2010|207
Cyclin D1 as a Diagnostic Immunomarker for Endometrial Stromal Sarcoma With YWHAE-FAM22 Rearrangement
|The American Journal of Surgical Pathology|2012|199